Skip to content

Investigations of vascular dysfunction and hypoperfusion in patients diagnosed with ME/CFS

Investigations of vascular dysfunction and hypoperfusion in patients diagnosed with ME/CFS - VADYS-ME

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00036730
Enrollment
90
Registered
2025-04-30
Start date
2025-05-21
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G93.3

Interventions

Group 1: The aim of this cross-sectional observational study is the pathophysiological characterization of vascular function and regulation, as well as organ perfusion, in patients with Chronic Fatigu

Sponsors

Charité - Universitätsmedizin Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: only for ME/CFS patients: ME/CFS diagnosis (ICD-10 G93.3) and fullfilling Canadian Consensus Criteria or IOM criteria

Exclusion criteria

Exclusion criteria: - Participation as a subject in a therapeutic study - Acute infectious disease with existing antiviral or antibacterial therapy. - Chronic inflammatory disease with immunosuppressive therapy - Acute or chronic cardiovascular disease with existing oral or intravenous therapy - Malignant diseases. Patients who have been relapse-free for more than 5 years can be included in the study. - Atrophic (neuro)muscular diseases - Metabolic diseases with existing drug therapy. - Psychological comorbidity - No informed consent for study participation - Pregnancy - Bell Score>80

Design outcomes

Primary

MeasureTime frame
This multicenter project aims to elucidate the role of vascular dysfunction and impaired perfusion in the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A shared patient cohort undergoes comprehensive clinical phenotyping, including detailed symptomatic, functional, and biochemical assessments. Vascular biomarker signatures with specificity for ME/CFS are derived from collected biosamples to enhance diagnostics, clinical stratification, and therapy monitoring. Pathophysiological alterations in skeletal muscle are investigated through indirect calorimetry, microdialysis, and muscle biopsy, focusing on energy metabolism and mitochondrial function. Retinal microcirculation is assessed using static and dynamic retinal vessel analysis and optical coherence tomography angiography (OCT-A). Cerebral vascular function and associated structural brain changes are evaluated via advanced magnetic resonance imaging (MRI) techniques. Cardiac investigations target myocardial perfusion and metabolism using specialized cardiac MRI protocols, including myocardial strain analysis and sodium spectroscopy. Collectively, the study integrates multimodal vascular and metabolic investigations to better understand disease mechanisms and identify potential diagnostic and therapeutic targets in ME/CFS.

Secondary

MeasureTime frame
comparison of cohorts

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026